Articles From: UPDATE: Merck drug shrank tumors in some breast cancer patients in trial to UPDATE: 10 oil-services companies that are ripe to be taken over


2014/12/10
By Peter Loftus A Merck & Co.
Sign-up for UPDATE: Merck drug shrank tumors in some breast cancer patients in trial investment picks
2014/12/19
By Peter Loftus AbbVie's Viekira Pak, a cocktail of several drugs, cured more than 90% of most common form of hepatitis C U.S. regulators on Friday approved AbbVie Inc.'s new multidrug regimen for hepatitis C, the latest in a wave of new medicines that is transforming treatment of the liver disease.
Sign-up for FDA approves AbbVie's hepatitis treatment investment picks
2014/12/8
By Peter Loftus and Dana CimillucaThe per-share bid of $102 is 37% above Friday's closing price of Cubist's stock Drug giant Merck & Co.
Sign-up for Merck to buy Cubist Pharmaceuticals for $8.4 billion investment picks
2014/11/24
By Peter Loftus Merck & Co.
Sign-up for Merck obtains right to experimental Ebola vaccine investment picks
2015/1/7
By Peter Nicholas Sen.
Sign-up for Elizabeth Warren Takes Aim at Democrats, Republicans investment picks
2014/10/28
By Philip van Doorn, MarketWatch Companies that consistently increase dividend payouts tend to outperform the broader market in the long run.
Sign-up for 5 'dividend aristocrat' stocks set to boost earnings up to 77% investment picks
2014/12/3
By Philip van Doorn, MarketWatch Highly indebted shale companies are in big trouble if crude prices remain low As investors expect oil prices to slide more, the big questions include: Which stocks will be hit the hardest, when will the price decline end and which shares eventually will be best to ride a rebound?
Sign-up for UPDATE: These U.S. oil producers have the most to lose investment picks
2014/11/5
By Philip van Doorn, MarketWatch It's been a lousy year for oil stocks as the price of crude has plummeted, but many U.S. oil production and service companies have actually posted huge sales gains.
Sign-up for UPDATE: 10 oil stocks that may eventually stage the biggest rebound investment picks
2014/10/28
By Philip van Doorn, MarketWatch Companies that consistently increase dividend payouts tend to outperform the broader market in the long run.
Sign-up for UPDATE: 5 'dividend aristocrat' stocks set to boost earnings up to 77% investment picks
2014/11/12
By Philip van Doorn, MarketWatch The benchmark index, meanwhile, sets records over five consecutive days Do you remember the "bubble" warnings after the S&P 500 Index (SPX) hit an intraday high on Sept.
Sign-up for UPDATE: 77 stocks in the S&P 500 Index rise to new highs investment picks
2014/11/28
By Philip van Doorn, MarketWatch OPEC has started a price war by deciding not to cut oil production The decision by OPEC on Thursday not to cut oil production, despite a price decline of over 30% since June, means U.S. shale-oil producers may soon find business to be unprofitable.
Sign-up for 10 U.S. shale-oil stocks getting crushed the most today investment picks
2014/12/9
By Philip van Doorn, MarketWatch Four in five shares are falling, dragged down by China woes A sharp decline for Chinese stocks set up a drop for the U.S. market.
Sign-up for UPDATE: Here are today's biggest S&P 500 losers ... and five winners investment picks
2014/12/2
By Philip van Doorn, MarketWatch Highly indebted shale companies are in big trouble if crude prices remain low As investors expect oil prices to slide more, the big questions include: Which stocks will be hit the hardest, when will the price decline end and which shares eventually will be best to ride a rebound?
Sign-up for UPDATE: These U.S. oil producers have the most to lose investment picks
2014/11/17
By Philip van Doorn, MarketWatch Halliburton's acquisition of Baker Hughes primes the pump for more M&A in the industry Following a few days of nastiness, Halliburton Co.
Sign-up for 10 oil-field-services companies that are ripe to be taken over investment picks
2014/12/3
By Philip van Doorn, MarketWatch The Lone Star state, home to the energy industry, suffers collateral damage Oil companies aren't the only ones taking a pounding from the tumble in crude prices.
Sign-up for Texas bank stocks dinged by drop in oil prices investment picks
2014/11/11
By Philip van Doorn, MarketWatch Despite worries over the global economy, U.S. companies are faring well Companies in the S&P 500 Index, despite concerns of a slowdown in global economic growth, are increasing revenue at twice the pace of the U.S. economy.
Sign-up for UPDATE: 10 S&P 500 companies with the fastest revenue growth investment picks
2014/11/4
By Philip van Doorn, MarketWatch "The largest and most persistent active investment opportunity is long-horizon mean reversion." That statement may not be the easiest to understand, but it essentially means that separating your emotions from investment decisions can make you a lot of money.
Sign-up for UPDATE: Why 'loser' stocks are actually long-term winners investment picks
2014/12/22
By Philip van Doorn, MarketWatch Your research may tell you that some companies have been unfairly punished As we start the holiday week, one way to identify possible stock market presents for 2015 is to look at this year's worst performers.
Sign-up for How to find 'winners' among the worst S&P 500 stocks investment picks
2014/12/18
By Philip van Doorn, MarketWatch It's been a decent year for the market overall, in spite of all the warnings from bears Heading into the holidays, it's a good time to take a look at which market sectors and which stocks have posted the year's strongest and weakest performances.
Sign-up for Here are the best S&P 500 stocks and sectors of 2014 investment picks
2014/10/23
By Philip van Doorn, MarketWatch Analysts are upbeat about the prospects for large-cap U.S. industrial stocks, so we have listed the 10 with the biggest potential upside based on consensus price targets.
Sign-up for UPDATE: 10 industrial stocks with the potential to rise up to 41% investment picks
2014/11/17
By Philip van Doorn, MarketWatch Despite the losses, some have performed well on the stock market You probably see "best stocks" articles regularly, but it might be just as important to read those that highlight the worst so you know which to avoid.
Sign-up for UPDATE: 13 U.S. companies that just keep losing money investment picks
2014/11/10
By Philip van Doorn, MarketWatch Despite worries over the global economy, U.S. companies are faring well Companies in the S&P 500 Index, despite concerns of a slowdown in global economic growth, are increasing revenue at twice the pace of the U.S. economy.
Sign-up for UPDATE: 10 S&P 500 companies with the fastest revenue growth investment picks
2014/12/11
By Philip van Doorn, MarketWatch These companies had double-digit increases in sales per share even before November's solid retail-sales report After disappointing retail-sales reports around Thanksgiving, investors cheered on Thursday, when the Department of Commerce said U.S. retail sales rose 0.7% during November, the best performance in eight months.
Sign-up for 10 retailers with the best sales growth this year investment picks
2014/12/11
By Philip van Doorn, MarketWatch There may be a few better alternatives, but none have lower fees and a longer track record The most widely read MarketWatch article Thursday is "Ignore John Bogle and dump your S&P 500 index fund" by Nicholas Vardy.
Sign-up for Most investors ought to stick with Bogle and index funds investment picks
2014/12/9
By Philip van Doorn, MarketWatch Taking holiday sales out of the equation reveals an interesting list of winners You may be up to your ears in reading about Christmas sales.
Sign-up for UPDATE: 10 consumer companies with the best sales growth this year investment picks
2014/12/29
By Philip van Doorn, MarketWatch It's been a decent year, in spite of all the warnings from bears Heading into the holidays, it's a good time to take a look at which market sectors and which stocks have posted the year's strongest and weakest performances.
Sign-up for UPDATE: Here are the best S&P 500 stocks and sectors of 2014 investment picks
2015/1/9
By Philip van Doorn, MarketWatch The Paris terrorist attack, falling oil prices and strong car sales led the news MarketWatch rounded up the 10 most important news events of the past week.
Sign-up for 10 biggest financial-market events this week investment picks
2014/12/19
By Philip van Doorn, MarketWatch It's been a decent year, in spite of all the warnings from bears Heading into the holidays, it's a good time to take a look at which market sectors and which stocks have posted the year's strongest and weakest performances.
Sign-up for UPDATE: Here are the best S&P 500 stocks and sectors of 2014 investment picks
2014/11/21
By Philip van Doorn, MarketWatch A big oil merger, Japan's recession and a pipeline setback led the news MarketWatch rounded up the 10 most important news events of the past week.
Sign-up for 10 biggest financial-market events this week investment picks
2014/11/17
By Philip van Doorn, MarketWatch Halliburton's acquisition of Baker Hughes primes the pump for more M&A in the industry Following a few days of nastiness, Halliburton Co.
Sign-up for UPDATE: 10 oil-services companies that are ripe to be taken over investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: UPDATE: Merck drug shrank tumors in some breast cancer patients in trial to UPDATE: 10 oil-services companies that are ripe to be taken over
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent